A
AFT Pharmaceuticals Ltd
NZX:AFT
AFT Pharmaceuticals Ltd
NZX:AFT
Price:
2.97 NZD
-1%
Market Closed
Updated:
May 7, 2024
AFT Pharmaceuticals Ltd
Cash from Operating Activities
|
AFT Pharmaceuticals Ltd
Cash from Operating Activities Peer Comparison
Comparables:
BLT
CBD
RUA
G
GFI
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
AFT Pharmaceuticals Ltd
NZX:AFT
|
Cash from Operating Activities
NZ$13.1m
|
CAGR 3-Years
30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
BLIS Technologies Ltd
NZX:BLT
|
Cash from Operating Activities
NZ$106k
|
CAGR 3-Years
-68%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Cannasouth Ltd
NZX:CBD
|
Cash from Operating Activities
-NZ$5.4m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-87%
|
CAGR 10-Years
N/A
|
|
|
Rua Bioscience Ltd
NZX:RUA
|
Cash from Operating Activities
-NZ$5.9m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
G
|
Greenfern Industries Ltd
NZX:GFI
|
Cash from Operating Activities
-NZ$1.4m
|
CAGR 3-Years
-58%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is AFT Pharmaceuticals Ltd's Cash from Operating Activities?
Cash from Operating Activities
13.1m
NZD
13.1m
NZD
Based on the financial report for Sep 30, 2023, AFT Pharmaceuticals Ltd's Cash from Operating Activities amounts to 13.1m NZD.
What is AFT Pharmaceuticals Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
30%
30%
Over the last year, the Cash from Operating Activities growth was -1%. The average annual Cash from Operating Activities growth rates for AFT Pharmaceuticals Ltd have been 30% over the past three years .
You don't have any saved screeners yet
